-
公开(公告)号:US11896645B2
公开(公告)日:2024-02-13
申请号:US17177614
申请日:2021-02-17
IPC分类号: A61K38/17 , C12N15/113 , C07K14/705 , A61P17/06 , A61P21/00 , A61P9/10 , A61P39/00 , A61P3/10 , A61P35/04 , A61P19/10 , A61K39/395 , C07K16/28
CPC分类号: A61K38/177 , A61K39/395 , A61P3/10 , A61P9/10 , A61P17/06 , A61P19/10 , A61P21/00 , A61P35/04 , A61P39/00 , C07K14/70546 , C07K16/28 , C12N15/113 , C12N2310/14
摘要: The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.
-
公开(公告)号:US20210169974A1
公开(公告)日:2021-06-10
申请号:US17177614
申请日:2021-02-17
IPC分类号: A61K38/17 , C12N15/113 , A61P17/06 , A61P21/00 , A61P9/10 , A61P39/00 , A61P3/10 , A61P35/04 , A61P19/10 , A61K39/395 , C07K14/705 , C07K16/28
摘要: The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.
-
3.
公开(公告)号:US20180325997A1
公开(公告)日:2018-11-15
申请号:US15773453
申请日:2016-11-07
IPC分类号: A61K38/17 , C07K14/705 , A61K39/395 , A61P17/06 , A61P19/10 , A61P21/00 , A61P3/10 , A61P35/04 , A61P39/00 , A61P9/10 , C07K16/28 , C12N15/113
CPC分类号: A61K38/177 , A61K39/395 , A61P3/10 , A61P9/10 , A61P17/06 , A61P19/10 , A61P21/00 , A61P35/04 , A61P39/00 , C07K14/70546 , C07K16/28 , C12N15/113 , C12N2310/14
摘要: The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.
-
-